Healthcare -
Biotechnology - NASDAQ - US
$ 0.757
-0.264 %
$ 41.7 M
Market Cap
-0.43
P/E
PRLD - CASH FROM OPERATIONS
Cash from Operations PRLD - Prelude Therapeutics Incorporated
-107 M
LAST VALUE
-13.21%
2 YEAR CAGR
-52.56%
5 YEAR CAGR
0.00%
10 YEAR CAGR